Sitagliptin promising addition for preventing acute GVHD
(HealthDay)—For patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation, sitagliptin combined with tacrolimus and sirolimus results in a low incidence of grade II to IV acute graft-versus-host ...
Jan 7, 2021
0
1